Sponsor content
110 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VeraSeal solutions for sealant 2 mL (Human fibrinogen 80 mg/mL syringe 1 mL / Human thrombin 500 IU/mL syringe 1 mL).
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Interpretive software IVDs.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Inborn/inherited genetic disorder IVDs.
-
Australian Public Assessment Report (AusPAR)AusPAR for Xembify (human normal immunoglobulin) for the treatment of primary immunodeficiency diseases.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Fluid transfer set, general-purpose.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Intravenous fluid container, single use.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd - Immunohaematology calibrator/control IVDs.
-
Prescription medicine decision summaryTGA decision: Xembify (normal immunoglobulin human) is approved to treat primary immunodeficiency diseases (PID).
-
Australian Public Assessment Report (AusPAR)VeraSeal (human fibrinogen and human thrombin) for the supportive treatment of hemostasis.